According to the NHS website, while floaters - such as dots and lines - or flashes of light in your vision are typically ...
The kinase inhibitor is now approved for adults and children aged ≥ 2 years with neurofibromatosis type 1 who have ...
IZERVAY dosing approved beyond 12 months TOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today ...
If you look up at the sky on a clear day, you might notice little cobweb-like structures drifting across your field of vision ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
A late night, another patient in distress or a tiff with the spouse—patients will never know the worries that weigh on their ...
The new vaccine is "personalized," meaning it is designed to train the patient's immune system to recognize and eliminate any remaining cells of that person's cancer.